Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. - Wikidata - wikimedia - TriplyDB

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

http://www.wikidata.org/entity/Q44578262

about

The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis The Apelin-APJ System in the Evolution of Heart Failure Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension Apelin increases cardiac contractility via protein kinase Cε- and extracellular signal-regulated kinase-dependent mechanisms Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice Interactions between apelin and angiotensin II on rat portal vein Apelin increases contractility in failing cardiac muscle Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver.Modulation of canine cardiac sodium current by Apelin Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses.Modulation of the apelin/APJ system in heart failure and atherosclerosis in man Angiopoietins, abdominal aortic aneurysm and atherosclerosis.Interactive association of five candidate polymorphisms in Apelin/APJ pathway with coronary artery disease among Chinese hypertensive patients.Prospective transcriptomic pathway analysis of human lymphatic vascular insufficiency: identification and validation of a circulating biomarker panel Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.Inflammatory manifestations of experimental lymphatic insufficiency Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker?Functional genomics applied to cardiovascular medicine.Apelin and pulmonary hypertension.Expression profiling of cardiovascular disease.Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli Apelin retards the progression of diabetic nephropathy Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity.Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure.Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart.The role of apelin in cardiovascular function and heart failure.Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.Apelin is a positive regulator of ACE2 in failing hearts.Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure?

P2860

Q24643958-52558929-2877-4874-B166-C612208B030F Q24657323-34B7E9AE-06AB-450F-8A26-1DC88C389496 Q26777306-0B7D0B07-5403-425B-8FE9-2D88CB2BE276 Q26823618-199341B3-A1EB-4E68-9C14-95654BAD7164 Q27010531-E116333F-DB0A-453B-8ED0-633EBD68351C Q28237326-D6C67B31-EDE9-46C0-9CA0-42EE6BCDD035 Q28472242-9E53554C-6466-418F-8FAC-5A3CC052547F Q28573763-FDE85F44-AE17-4DF9-BE59-4B5BAB722EE7 Q28579590-2CA68AD6-51FE-4B39-A9D0-EB9A0BF19AC3 Q28750147-5E219363-C861-4F9D-B2CE-299BAE271C36 Q30484162-CE310B9C-BA61-4CB4-8B6D-1DF6FD5FA6B4 Q33354126-D5400E55-AB38-4136-A1B0-22F3CBB22F5F Q33666996-86DC4A5E-2B61-49AA-8F18-4AFEC50F3A89 Q33724481-EFF576C3-D593-4CE9-A575-48C05E03801F Q33906868-0AED2F6D-9BBE-4A45-BA69-FA1792900519 Q34002877-60C06D07-12C5-47C5-803B-C5698133F5AA Q34044227-6788DFAB-BDAF-400D-95BE-159F346434C0 Q34078505-5A79A107-4F24-47F5-88A8-CE2105E8BBE4 Q34116830-DC26F36F-A06C-4936-8A35-E1E50C932FB7 Q34451437-00BDEB14-28C8-4910-8F99-E9FEA82EB854 Q34506746-E2902278-AC82-441E-BCE6-3682BFB6CD99 Q34525884-750217F8-1C99-4BBB-9043-B894C9ECBFA4 Q34548928-96FFC33B-17DC-4978-A0AB-77E4BCA56B09 Q34770407-04FB1484-5761-45B9-8C3E-4F092EF3F1AB Q35040806-9B6B7074-19FB-4E38-8B6B-EB396E915CD7 Q35085476-32AC7A36-D16F-4FF2-956E-EE349A166EC3 Q35110769-23E150F6-C6E3-468A-9267-B1EC9F596AC4 Q35573931-8A3B25FE-C19F-4B28-8330-8EBE750329CB Q35978591-F5793F29-B44F-4860-B55F-CC5642F34D13 Q36095672-0BFAE27C-9951-45B9-94B3-70F5A8D68F51 Q36495941-557A64F7-70D2-4D53-A637-4F9DDE5768E2 Q36662125-74A5A988-8A7A-4B8C-87A2-A111AA610456 Q36699804-B7B81FFA-56B2-4222-91A4-C584E6C1DB8D Q36867583-17BB7DD1-CCD8-4181-AA1E-28279E27EB01 Q36998541-C8E18DEB-154D-4A09-B09E-AD44251E054F Q37161801-A96EF71F-6A00-4BCE-BE81-803585A3E27E Q37201175-7B0C093D-C850-4398-A472-894F34372B12 Q37310459-082B9065-F81A-4A26-86A7-87034FE7D9B8 Q37383989-20F1BBF2-13E8-46B9-9CE3-642743669D1D Q37389353-8114CA19-3B3E-4423-A6FD-0EADED45F30D

P2860

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

http://www.wikidata.org/entity/Q44578262

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@en

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@nl

type

label

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@en

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@nl

prefLabel

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@en

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@nl

P1433

Q44578262-28E9D6C5-7A45-44A6-B1FA-3C271198F15A

P1476

Q44578262-A3BAA34F-0B87-4327-8206-966B9A4D9262

P2093

Q44578262-051F80E1-26E1-4C9B-B4CF-EC933E72A5A9

Q44578262-18AC9C51-EF4B-4E87-B86C-647F48F43492

Q44578262-35540D61-4354-41D4-A488-54D00303CF69

Q44578262-3642E47F-FACB-45C8-9BD3-582ADB96E350

Q44578262-48FAEBC5-C88C-4FAE-AFB0-09BAA6929CAB

Q44578262-672E27F4-2B24-45BF-9203-3AE31E857E5E

Q44578262-7C7BCF64-CB52-4837-B8BD-A7C9A9C4C4D2

Q44578262-8D155DB8-E3BF-4663-B469-FE90897A3AEA

Q44578262-93129408-2076-48DA-B406-84B448E2A8D5

Q44578262-A5127DBB-0944-4AAF-9435-3B9A4075F91E

P304

Q44578262-5B9C8206-874F-408B-9382-C662A26D6FDF

P31

Q44578262-A895AB40-FAEA-49A3-8D9F-E96AFA037914

P356

Q44578262-82135B81-7CFB-4C1F-88BD-A9268E46296B

P407

Q44578262-FE29D9EB-0300-42CD-B07A-62BA542A42C4

P433

Q44578262-BCAD9041-B15F-4449-BDB5-75359BD752AB

P478

Q44578262-72F1D42A-D52F-4E11-B2C1-C989449CD21B

P50

Q44578262-2506494F-A03A-480C-9FB4-2F73A184EAD1

Q44578262-D14464A9-793A-4B37-BE3F-6BE07B94B43A

P577

Q44578262-A42FAD26-01E5-4401-94A0-4ED9FE71DE3C

P698

Q44578262-B5C4FB2F-A8DE-45A3-ACC8-69A5AC09063B

P356

01.CIR.0000091235.94914.75

P1433

P1476

Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.

@en

P2093

Alicia Deng

http://www.w3.org/2001/XMLSchema#string

Amir Ben-Dor

http://www.w3.org/2001/XMLSchema#string

Anya Tsalenko

http://www.w3.org/2001/XMLSchema#string

Brett Fenster

http://www.w3.org/2001/XMLSchema#string

David X F Deng

http://www.w3.org/2001/XMLSchema#string

Euan A Ashley

http://www.w3.org/2001/XMLSchema#string

Eugene Yang

http://www.w3.org/2001/XMLSchema#string

Frances L Johnson

http://www.w3.org/2001/XMLSchema#string

Henry Dargie

http://www.w3.org/2001/XMLSchema#string

Jennifer Y King

http://www.w3.org/2001/XMLSchema#string

P304

1432-1439

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000091235.94914.75

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Quertermous

Raymond Tabibiazar

P577

2003-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12963638

http://www.w3.org/2001/XMLSchema#string